Gapping down
In reaction to earnings/guidance:
- HUYA -6.9%, TME -1.5%
Other news:
- ALT -39.6% (results from week 24 interim analysis of pemvidutide momentum phase 2 obesity trial and 12-week phase 1b type 2 diabetes safety trial)
- AG -15.2% (suspending mining at Jerritt Canyon)
- SI -6% (delaying 10-K filing)
- FSM -2.5% (reports updated Mineral Reserves and Mineral Resources)
- FMC -2.3% (to introduce long-range growth plan)
- CTRE -1.5% (increases quarterly dividend)
- PBT -1.5% (announces March cash distribution)
- KRTX -1.4% (commences $400 mln public offering)
Analyst comments:
- GDDY -1.4% (downgraded to Neutral from Overweight at Piper Sandler)